Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescence in Salvage Surgery for Recurrent Head and Neck Cancer
NCT02920216Completed
- Sponsor
- Institut de Cancérologie de Lorraine
- Start
- Dec 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green in head and neck squamous cell carcinoma (HNSCC), sponsored by Institut de Cancérologie de Lorraine. Primary endpoint: Sensitivity of indocyanine green labeling in Irradiated Area at 1 day. Started Dec 2016; status: completed.
02
Drugs
indocyanine green
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02920216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02920216.